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Abstract 
Introduction: Periodontitis is a common disease in patients with diabetes. There is a significant 
relationship between hyperglycemic degree and severity of periodontitis, but the base of 
mechanism of this relationship has not been fully defined. Considering the important role of 
cytokines in periodontal pathogenesis and considering that there has been no study on the 
comparison of interleukin 35 (IL-35) in these diseases, the aim of this study was to determine the 
level of this salivary cytokine in patients with type 2 diabetes mellitus with generalized moderate 
chronic periodontitis. 
Material & Methods: Totally, 88 subjects (44 female, 44 males) with a mean age of 42.5±10.5 
years old participated in this case control study. The subjects were divided into four groups and 
each group included 22 subjects: Group 1: generalized moderate chronic periodontitis patients 
with type 2 diabetes, Group 2: generalized moderate chronic periodontitis patients without 
diabetes, Group 3: diabetic patients with normal periodontium, Group 4: healthy periodontium and 
non-diabetic group (control) Then saliva were collected and centrifuged, the amount of IL-35 was 
determined with commercial ELISA kit. Data were analyzed . ANOVA and Tukey post-hoc tests 
were used to compare the groups. 
Results: The Mean±SD of IL-35 was significantly higher in the control group (22.59±8.36, 
p<0.05) than other groups (Group1: 13.12±5.62, Group2: 14.27±8.55, Group3: 15.12±8.13). Mean 
comparison of IL-35 in other groups had no significant difference (P>0.05). 
Conclusion: The salivary IL-35 level is decreased in both periodontitis and type 2 diabetes. 
However, diabetes mellitus does not exacerbate this decline in patients with periodontitis. 
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 چکيدٌ
بیي درجِ ّایپرگلایعوی ٍ شذت پریَدًتیت ٍجَد  داری یاظت. رابطِ هعٌهبتلایاى بِ دیابت در  شایعپریَدًتیت بیواری  :مقدمٍ
پریَدًتیت ٍ با تَجِ بِ پاتَشًس ّا در ظایتَکایيهْن هشخص ًشذُ اظت. با تَجِ بِ ًقش  ارتباط کاهلاًپایِ ایي هکاًیعن اها دارد. 
 بررظی ظطححاضر،  اًجام ًشذُ اظت ّذف از اًجام هطالعِ ّا یواریدر ایي ب 53در هَرد هقایعِ ایٌترلَکیي  یا ایٌکِ تاکٌَى هطالعِ
 .اظت جٌرالیسُ یَدًتیت هسهي هتَظطهبتلا بِ پر 2در بساق بیواراى دیابتی ًَع  ایي ظایتَکایي
شرکت  در ایي هطالعِ هَردی شاّذی ظال 24/5±01/5 با هیاًگیي ظٌی (هرد 44زى،  44)ًفر  88 هجوَعدر  :َب مًاد ي ريش
دارای  یسُجٌرال پریَدًتیت هسهي هتَظط: بیواراى ٍاجذ 1بَدًذ.  گرٍُ  ًفر 22 تقعین شذًذ ٍ ّر گرٍُ شاهل  گرٍُ 4. افراد بِ اًذ داشتِ
ًرهال ٍگرٍُ با پریَدًشیَم  بیواراى دیابتی  :3گرٍُ ، فاقذ دیابت جٌرالیسُپریَدًتیت هسهي هتَظط بیواراى ٍاجذ   :2گرٍُ ،2 دیابت ًَع
َکیي ایٌترلٍ پط از ظاًتریفیَش کردى، هیساى  یآٍر جوعی بساق، ّا ًوًَِ)، ظپط کٌترل(گرٍُ  با پریَدًشیَم ًرهال فاقذ دیابتافراد  :4
برای هقایعِ گرٍُ ّا تعت اهاری آًَا ٍ تعت تعقیبی تَکی  تحلیل شذًذ. ّا دادُشذ ٍ  تعییي ASILEتجاری بر اظاض  کیت با 53
 هَرد اظتفادُ قرار گرفتٌذ.
رٍُ ) از ظِ گرٍُ دیگر بیشتر بَد.(گ50.0 < pٍ  22/95±8/63در گرٍُ کٌترل ( 53اًحراف هعیار ایٌترلَکیي ±هیاًگیي :یبفتٍ َب
ّای دیگر تفاٍت در گرٍُ 53). هقایعِ هیاًگیي ایٌترلَکیي  51/21±8/31، گرٍُ ظِ:  41/72±8/55، گرٍُ دٍ: 31/21±5/26یک: 
 ).50.0>p( هعٌاداری را ًشاى ًذاد
ر با ایي حال ، دیابت هلیتَض ایي کاّش را د .کاّش هی یابذ 2بساق در پریَدًتیت ٍ دیابت ًَع  53-LI ظطح :وتيجٍ گيري
 .ًوی کٌذبیواراى هبتلا بِ پریَدًتیت تشذیذ 
 ، بساقپریَدًتیت هسهي هلیتَض، دیابت ياژگبن كليدي:
 
 noitcudortnI
 esaesid yrotammalfni latnodoirep a si sititnodoireP
 dna eussit evitcennoc fo ssol elbisreverri htiw detaicossa
 .enob raloevla gnitroppus
]1[
 yb desuac si esaesid sihT 
 muitnodoirep eht neewteb snoitcaretni xelpmoc
 ehT .sllec enummi tsoh eht dna snegohtap detaicossa
 eht rof elbisnopser era noitammalfni fo etis eht ni sllec
 eht ni devlovni era taht senikotyc fo noitcudorp
 .esaesid latnodoirep eht fo sisenegohtap
 ]2[
 cinorhC
 ,sititnodoirep fo mrof nommoc tsom eht si sititnodoirep
 ni srucco osla tub stluda ni nommoc erom si hcihw
 .stnecseloda dna nerdlihc
 ]4 ,3[
  fo sisongaid lacinilC
 eht sa hcus airetirc eht no desab si sititnodoirep cinorhc
 lavignig eht ni noitammalfni cinorhc fo ecneserp
 dna tekcop latnodoirep fo ecneserp eht ,nigram
 eht ni nees eb nac ssol tnemhcattA .ssol tnemhcatta
 lavignig ro/dna tekcop latnodoirep eurt a fo mrof
 .noissecer
]5[
 na si sutillem setebaid ,dnah rehto eht nO 
 setebaiD .muitnodoirep eht ot detaler esaesid tnatropmi
 cinorhc yb deziretcarahc redrosid cilobatem a si sutillem
 nilusni ,noitcudorp nilusni ni esaerced A .aimecylgrepyh
 stluser ,htob fo noitanibmoc a ro ,tnemriapmi noitcnuf
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in impaired glucose transfer and increased blood 
glucose levels as well as secretion of glucose in the 
urine. 
[6]
 According to available epidemiological data, 
the potential for periodontitis in people with diabetes is 
three times that of healthy people. 
[7]
 There is a clear 
relationship between diabetes and the severity of 
periodontitis. The mechanism of the relationship 
between these two diseases is not well defined, but it 
can be affected by the activity of the immune system 
and its related molecules, particularly cytokines. 
[8]
 A 
variety of possible mechanisms such as oxidative stress 
and inflammatory immune responses are still under 
investigation. People with diabetes have higher levels of 
malondialdehyde and lower levels of glutathione, 
indicating oxidative stress in hyperglycemia. [9] Both 
type 1 and type 2 diabetes are associated with an 
increased level of systemic inflammatory markers. 
Accordingly, serum levels of IL-6 and CRP (C Reactive 
Protein) are high in periodontitis. 
[8]
 Therefore, the 
likeness of both diseases is their inflammatory nature. 
Inflammatory diseases are exacerbated by inflammatory 
cytokines such as IL-6, TNF-α, IFN-γ, IL-12, and 
reduced by anti-inflammatory cytokines such as IL-10 
and IL-35. The balance between these cytokines 
determines the mechanism of inflammatory diseases. 
IL-35 is a new member of the IL-12 family. 
[10]
 IL-
12 is one of the cytokines involved in inflammatory 
reactions in many pathological and physiological 
processes. 
[11]
 It has been shown in some studies that IL-
35 is involved in moderating immunity in a severe stage 
of the disease. 
[10]
 Besides, the anti-inflammatory role of 
IL-35 has been already recognized in research 
[12]
, while 
other members of the IL-12 family have illustrated the 
role of immunosuppressive. 
[13]
  
Recent studies have indicated that IL-35 is an anti-
inflammatory cytokine that suppresses the immune 
response through the proliferation of Treg and 
suppression of Th17 cell growth. This suggests a 
possible role for IL-35 in chronic inflammation such as 
periodontitis. However, little is known about the exact 
mechanism. 
[14]
 Considering the issues mentioned 
above, the vital role of inflammatory cytokines in the 
pathogenesis of periodontitis and diabetes in addition to 
the higher prevalence of periodontitis in diabetic 
patients, and since there has not been a study on the 
comparison of IL-35 in these diseases, this study 
evaluated the level of IL-35 in saliva of type 2 diabetic 
patients with generalized moderate chronic 
periodontitis. To the aim of the current study was to 
answer these questions whether, firstly, reducing this 
cytokine can advance the equilibrium in both diseases to 
inflammation, and secondly, diabetes may exacerbate 
this possible decline to justify the relationship between 
diabetes and periodontitis. 
 
 
Materials & Methods 
This experimental study was approved by the Ethical 
Committee of Babol University of Medical Sciences 
(Ethical number: mubabol.rec.1396.4427). The 
statistical population of this study included 88 samples 
divided into four groups: a) 22 patients with generalized 
moderate chronic periodontitis with type 2 diabetes, b) 
22 patients with generalized moderate chronic 
periodontitis without type 2 diabetes, c) 22 patient with 
diabetes and normal periodontium, and d) 22 healthy 
subjects with normal periodontium as a control group. 
Diabetic patients were also matched for the duration of 
the disease. 
The study population was selected from patients 
referred to the Periodontology Department of Babol 
Dental School and the Department of the Endocrinology 
of Ayatollah Rohani Hospital in Babol from February to 
April 2017. Simple sampling was carried out, and the 
sample size was calculated as 22. This is a case-control 
study, and 22 patients were sampled in each. 
These patients have been selected based on the 
clinical diagnosis of periodontitis in persons with at 
least 20 teeth and diabetic disease in their medical 
history. In addition, the exclusion criteria were 
pregnancy and lactation, patients receiving topical or 
systemic antibiotics in the last six months as well as 
having dental and periodontal abscesses. 
[10]
 In terms of 
clinical diagnosis, the criteria for the presence of 
generalized moderate chronic periodontitis in patients 
was having pocket depth between 5 and 7 millimeters, 
presence of bleeding on probing and clinical attachment 
loss of 3 to 4 millimeters. 
[15]
 
After confirming the diagnosis, saliva samples were 
collected as follows: samples were collected between 9 
to 12 A.M, and people were asked to refrain from 
eating, drinking, chewing gum and smoking for at least 
two hours before sampling. At first, the participants 
swallowed the saliva, then bend the head to the front 
and poured all of the saliva for 5 minutes in a special 50 
milliliters dry tube for centrifugation. 
All specimens were centrifuge(Sigma-Aldrich, 
Munich, Germany) at 4°C for 20 minutes at a speed of 
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6000 rpm to separate cell debris and then were kept at -
80°C for evaluating with Elisa commercial kit (Crystal 
day,Shanghai,China)with the ability to measure the IL-
35 in saliva at a sensitivity of picogram per milliliter.
[16]
 
The collected data were analyzed using SPSS 18. 
Descriptive statistics were reported as mean ± SD. 
ANOVA test was used for comparing the groups, and 
P<0.05 was considered significant level. Tukey post hoc 
test was used to compare the two groups. 
 
 
Results 
Generally, 10 males and 12 females with the mean 
age of 26.09± 3.15 years in control group, 10 females 
and 12 males with the mean age of 47.1±4.51 years in 
periodontitis group, 11 males and 11 females with the 
mean age of 48.8±6.51 years in the periodontitis+ 
diabetes group and 11 males and 11 females with the 
mean age of 47.7±4.27 years in diabetes group 
participated in this study. The results of comparing the 
average of IL-35 concentration in studied groups are 
illustrated in figure1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1. Comparison of Interleukin-35 average in the 
studied groups  
 
 According to the results shown in figure1, 
comparing the IL-35 concentration in pg/ml using one-
way ANOVA and Tukey's post-hoc test with 95% 
confidence interval demonstrated that the difference in 
concentration between the control and other groups was 
statistically significant (p<0.001). The difference 
between groups was not significant sexually (P=0.94), 
and the level of IL-35 had no significant difference 
between males and females. The difference between 
groups in terms of age was significant (P<0.001), while 
the mean age in the control group was significantly 
lower than in other groups.  
 Three-way analysis of variance (3-way ANOVA) 
illustrated that after controlling the effects of age and 
sex, there was a significant difference between the IL-
35 median (F=3.34, df=3, p=0.02). For comparing the 
means of IL-35 between four groups pairwisely, the 
Tukey's post-hoc test was used. The results of this test 
showed that the mean of IL-35 in the control group was 
significantly higher than the other three groups, for 
example, p=0.005 relative to the periodontitis group, 
p=0.001 relative to periodontitis and diabetes and 
p=0.01 relative to diabetic group. In other cases, this 
difference was not significant. 
 
 
Discussion 
The present study evaluated the salivary levels of 
interleukin 35 among type 2 diabetic patients suffering 
from generalized moderate chronic periodontitis. The 
lowest levels of salivary IL-35 were observed among 
the patients having both type 2 diabetes and 
periodontitis. They were followed by patients with 
periodontitis and then diabetes, respectively. Levels of 
IL-35 in the saliva of healthy controls were significantly 
higher than in other groups. 
 Mitani et al. conducted a study on the levels of IL-
35, IL-17, and IL-27 in the gingival crevicular fluid 
(GCF) and gingival tissues of patients with 
periodontitis. They suggested that IL-35 and IL-17 have 
higher levels among the samples taken from patients 
having periodontitis than healthy subjects. 
[13]
 Kalburgi 
et al. studied the gingival expression of IL-35 mRNA in 
patients with periodontitis. They showed that IL-35 
mRNA was higher in patients with chronic periodontitis 
than in patients having aggressive periodontitis. The 
expression level of IL-35 mRNA was the lowest in 
healthy controls. 
[11]
 Maboudi et al. indicated that they 
found no significant alteration in the serum levels of IL-
35 and IL-23 among patients with type 2 diabetes and 
chronic periodontitis as well as healthy subjects. 
[17]
 
 These differences may best be explained due to the 
difference in the sampling sites. In the ongoing study, 
we used salivary samples, while in the previously 
mentioned studies, they took samples from gingival 
crevicular fluid, gingival tissues and serum of the 
patients. 
Köseoğlu et al. performed a study on the levels of 
IL-35 in GCF, plasma, and saliva of patients suffering 
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from periodontitis. The results implied that IL-35 was 
higher in the GCF of patients with periodontitis. 
However, the levels of IL-35 in plasma samples had no 
significant differences. Similar to our findings, they 
stated that salivary levels of IL-35 were higher in 
healthy controls than patients with periodontitis. They 
explained that the salivary concentration of IL-35 is 
lower in the patients as a result of breakdown due to the 
salivary proteases. 
[10]
 
 It should be taken into consideration that the 
expression level of IL-35 can be affected by other risk 
factors. According to previous studies, other 
environmental and systemic factors may affect 
periodontal status; for instance, new researches have 
suggested that pro-inflammatory cytokines tend to reach 
higher levels in patients suffering from periodontal 
disorders accompanying smoking. 
[18, 19]
 The same thing 
occurs among immunodeficient patients whose systemic 
condition is associated with more severe and frequent 
refractory chronic periodontitis. 
[20] 
 It is crucial to have 
it in mind that we have studied patients with generalized 
moderate chronic periodontitis and used salivary 
samples. Sampling from other sites or other types of 
periodontal diseases may express different results. 
 Previously, levels of interleukin 35 were not studied 
in the saliva of diabetic patients suffering from chronic 
periodontitis. Due to the limited fund of the project, and 
interleukin kit price, only saliva samples were used for 
further analyses. 
 
 
Conclusion 
 In this study, the lowest level of interleukin 35 was 
observed in the saliva of the diabetic + periodontitis 
group, and the periodontitis group and the diabetic 
group were assigned to the next. All groups showed 
significantly lower levels of interleukin-35 than the 
control group. Moreover, in other cases, no significant 
difference was observed. Patients with periodontitis had 
a reduced level of IL-35 in their saliva. This decrease 
was not related to type 2 diabetes. 
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